603538.SH
美诺华
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 26.40
−7.40%Margins
Gross margin
34.0%
EBITDA margin
17.3%
EBIT margin
8.9%
Net margin
7.2%
FCF margin
1.8%
4.7%
Return on equity
2.4%
Return on assets
4.6%
Return on invested capital
0.33x
Asset turnover
CNY 156.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026